- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Pathology of Non–Small Cell Lung Cancer
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Volume 138, Issue 3, Pages 332-346
Publisher
Oxford University Press (OUP)
Online
2012-08-22
DOI
10.1309/ajcpfr12wjkceezz
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC).
- (2017) D. R. Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- Non–Small Cell Lung Cancer
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
- (2012) A J Atherly et al. BRITISH JOURNAL OF CANCER
- Identifying and Targeting ROS1 Gene Fusions in Non-Small Cell Lung Cancer
- (2012) K. D. Davies et al. CLINICAL CANCER RESEARCH
- Mechanisms of Resistance to Crizotinib in Patients withALKGene Rearranged Non–Small Cell Lung Cancer
- (2012) Robert C. Doebele et al. CLINICAL CANCER RESEARCH
- Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
- (2012) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- Individualized therapy for patients with non-small cell lung cancer: Emerging trends and challenges
- (2012) Corey J. Langer CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Treatment of nonsmall cell lung cancer
- (2012) Corey A. Carter et al. CURRENT OPINION IN ONCOLOGY
- Respiratory cytology in the era of molecular diagnostics: A review
- (2012) Benjamin L. Witt et al. DIAGNOSTIC CYTOPATHOLOGY
- The role of cytology specimens in molecular testing of solid tumors: Techniques, limitations, and opportunities
- (2012) Dara L. Aisner et al. DIAGNOSTIC CYTOPATHOLOGY
- Prognostic and Predictive Value of K-RAS Mutations in Non-Small Cell Lung Cancer
- (2012) Raffaele Califano et al. DRUGS
- Emerging New Agents for the Management of Patients with Non-Small Cell Lung Cancer
- (2012) Enrica Capelletto et al. DRUGS
- Gefitinib for a Poor Performance Status Patient with Squamous Cell Carcinoma of the Lung Harboring EGFR Mutation
- (2012) Kosuke Tanaka et al. INTERNAL MEDICINE
- Molecular Profiling to Optimize Treatment in Non-Small Cell Lung Cancer: A Review of Potential Molecular Targets for Radiation Therapy by the Translational Research Program of the Radiation Therapy Oncology Group
- (2012) Natalie L. Ausborn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Benefits and Harms of CT Screening for Lung Cancer
- (2012) Peter B. Bach et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma
- (2012) Jamie E. Chaft et al. Journal of Thoracic Oncology
- Preclinical Rationale for Use of the Clinically Available Multitargeted Tyrosine Kinase Inhibitor Crizotinib in ROS1-Translocated Lung Cancer
- (2012) Hiroyuki Yasuda et al. Journal of Thoracic Oncology
- High Incidence of EGFR Mutations in Korean Men Smokers with No Intratumoral Heterogeneity of Lung Adenocarcinomas: Correlation with Histologic Subtypes, EGFR/TTF-1 Expressions, and Clinical Features
- (2012) Ping-Li Sun et al. Journal of Thoracic Oncology
- Chipping away at the lung cancer genome
- (2012) William Pao et al. NATURE MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
- (2012) R. Katayama et al. Science Translational Medicine
- The Biology and Clinical Features of Non–small Cell Lung Cancers with EML4-ALK Translocation
- (2012) Rathi N. Pillai et al. Current Oncology Reports
- The Application of Molecular Diagnostic Studies Interrogating EGFR and KRAS Mutations to Stained Cytologic Smears of Lung Carcinoma
- (2011) Bryan L. Betz et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Adenosquamous Carcinoma of the Lung
- (2011) Naobumi Tochigi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Changes in smoking prevalence among U.S. adults by state and region: Estimates from the Tobacco Use Supplement to the Current Population Survey, 1992-2007
- (2011) Ahmedin Jemal et al. BMC PUBLIC HEALTH
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- EGFR gene status in cytological samples of nonsmall cell lung carcinoma
- (2011) Gilda da Cunha Santos et al. CANCER CYTOPATHOLOGY
- EGFR and KRAS mutations in lung carcinoma
- (2011) Shahreen Billah et al. CANCER CYTOPATHOLOGY
- New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer
- (2011) G. R. Oxnard et al. CLINICAL CANCER RESEARCH
- EGFR Mutation Status in Primary Lung Adenocarcinomas and Corresponding Metastatic Lesions: Discordance in Pleural Metastases
- (2011) Hye-Suk Han et al. Clinical Lung Cancer
- Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
- (2011) Arne Warth et al. EUROPEAN RESPIRATORY JOURNAL
- Laboratory methods forKRASmutation analysis
- (2011) Steven M Anderson EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Incidence ofEGFRExon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas
- (2011) Sandra P. D'Angelo et al. JOURNAL OF CLINICAL ONCOLOGY
- Heterogeneous Distribution of EGFR Mutations Is Extremely Rare in Lung Adenocarcinoma
- (2011) Yasushi Yatabe et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations
- (2011) Antonio Marchetti et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Characteristics of Patients With Lung Adenocarcinomas HarboringBRAFMutations
- (2011) Paul K. Paik et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy
- (2011) Vicki Leigh Keedy et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study
- (2011) Umberto Malapelle et al. JOURNAL OF CLINICAL PATHOLOGY
- Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
- (2011) J. Jean Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Therapeutic Targets in Non-small Cell Lung Cancer
- (2011) Filip Janku et al. Journal of Thoracic Oncology
- ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers
- (2011) Samuel J. Klempner et al. Journal of Thoracic Oncology
- A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer
- (2011) Peter M. Ellis et al. Journal of Thoracic Oncology
- Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed
- (2011) D. Ross Camidge et al. Journal of Thoracic Oncology
- Anaplastic Lymphoma Kinase Translocation: A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer
- (2011) Jeong-Ok Lee et al. Journal of Thoracic Oncology
- Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing
- (2011) Natasha Rekhtman et al. Journal of Thoracic Oncology
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Lung Adenocarcinomas with HER2-Activating Mutations Are Associated with Distinct Clinical Features and HER2/EGFR Copy Number Gains
- (2011) Chenguang Li et al. Journal of Thoracic Oncology
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung
- (2011) Xiao-Li Jia et al. LUNG CANCER
- Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: Implications for clinical practice and open issues
- (2011) C. Gridelli et al. LUNG CANCER
- Detection of the EGFR mutation in exhaled breath condensate from a heavy smoker with squamous cell carcinoma of the lung
- (2011) Dan Zhang et al. LUNG CANCER
- Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers
- (2011) Kenji Tomizawa et al. LUNG CANCER
- The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group
- (2011) Erik Thunnissen et al. LUNG CANCER
- Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras
- (2011) Kazuya Takamochi et al. LUNG CANCER
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Pathological Diagnosis and Classification of Lung Cancer in Small Biopsies and Cytology: Strategic Management of Tissue for Molecular Testing
- (2011) William Travis et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond
- (2011) Sai-Hong Ignatius Ou Drug Design Development and Therapy
- Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities
- (2011) Elizabeth M. Gaughan et al. Therapeutic Advances in Medical Oncology
- Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples
- (2010) Jefferson Terry et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens
- (2010) Sanjay Mukhopadhyay et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Synchronous Primary Lung Cancer and Epidermal Growth Factor Receptor Mutation
- (2010) Edmond S.K. Ma et al. ANNALS OF THORACIC SURGERY
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment
- (2010) D. R. Camidge et al. CLINICAL CANCER RESEARCH
- Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer
- (2010) K. Suda et al. CLINICAL CANCER RESEARCH
- Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: A review
- (2010) Umberto Malapelle et al. DIAGNOSTIC CYTOPATHOLOGY
- The biology and treatment of EML4-ALK non-small cell lung cancer
- (2010) Takaaki Sasaki et al. EUROPEAN JOURNAL OF CANCER
- Personalized Medicine in Non–Small-Cell Lung Cancer: IsKRASa Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?
- (2010) Patrick J. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer
- (2010) Corey J. Langer et al. JOURNAL OF CLINICAL ONCOLOGY
- Archival Fine-Needle Aspiration Cytopathology (FNAC) Samples
- (2010) J. Keith Killian et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Reflex testing of resected stage I through III lung adenocarcinomas for EGFR and KRAS mutation: Report on initial experience and clinical utility at a single center
- (2010) Sandra P. D’Angelo et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop
- (2010) Robert Pirker et al. Journal of Thoracic Oncology
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- (2010) J. Weiss et al. Science Translational Medicine
- Molecular Testing in Lung Cancer: The Time Is Now
- (2010) Haiying Cheng et al. Current Oncology Reports
- EGFRand K-rasMutations Along the Spectrum of Pulmonary Epithelial Tumors of the Lung and Elaboration of a Combined Clinicopathologic and Molecular Scoring System to Predict Clinical Responsiveness to EGFR Inhibitors
- (2009) Giuliana Sartori et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
- (2009) Maurizio Infante et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene
- (2009) Tsuyoshi Takahashi et al. ANNALS OF SURGICAL ONCOLOGY
- TheEML4-ALKfusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-typeEGFRandKRAS
- (2009) Daisy Wing-Sze Wong et al. CANCER
- Use of Epidermal Growth Factor Receptor/Kirsten Rat Sarcoma 2 Viral Oncogene Homolog Mutation Testing to Define Clonal Relationships Among Multiple Lung Adenocarcinomas
- (2009) Nicolas Girard et al. CHEST
- Analysis of ErbB Receptors in Pulmonary Carcinoid Tumors
- (2009) O. B. Rickman et al. CLINICAL CANCER RESEARCH
- Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
- (2009) S. J. Rodig et al. CLINICAL CANCER RESEARCH
- A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases
- (2009) Sara E. Monaco et al. HUMAN PATHOLOGY
- Epidermal Growth Factor Receptor Mutations and the Clinical Outcome in Male Smokers with Squamous Cell Carcinoma of Lung
- (2009) Se Hoon Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort
- (2009) Michèle Beau-Faller et al. Journal of Thoracic Oncology
- Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib
- (2009) Marie Wislez et al. LUNG CANCER
- Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas
- (2009) Sanja Dacic et al. MODERN PATHOLOGY
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors
- (2009) T John et al. ONCOGENE
- Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
- (2008) A Kalikaki et al. BRITISH JOURNAL OF CANCER
- Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
- (2008) G. J. Riely et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now